Oppenheimer & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.4M | Buy |
831,613
+136,995
| +20% | +$3.65M | 0.28% | 59 |
|
|
2025
Q4 | $17.3M | Sell |
694,618
-8,787
| -1% | -$222K | 0.25% | 81 |
|
|
2025
Q3 | $17.9M | Buy |
703,405
+61,829
| +10% | +$1.53M | 0.22% | 92 |
|
|
2025
Q2 | $15.6M | Buy |
641,576
+5,361
| +0.8% | +$125K | 0.21% | 100 |
|
|
2025
Q1 | $16.1M | Buy |
636,215
+54,844
| +9% | +$1.44M | 0.24% | 77 |
|
|
2024
Q4 | $15.4M | Sell |
581,371
-77,017
| -12% | -$2.09M | 0.23% | 80 |
|
|
2024
Q3 | $19.1M | Buy |
658,388
+53,526
| +9% | +$1.56M | 0.29% | 67 |
|
|
2024
Q2 | $16.9M | Sell |
604,862
-2,490
| -0.4% | -$68.6K | 0.27% | 73 |
|
|
2024
Q1 | $16.9M | Buy |
607,352
+96,110
| +19% | +$2.67M | 0.28% | 72 |
|
|
2023
Q4 | $14.7M | Sell |
511,242
-138,238
| -21% | -$4.18M | 0.27% | 74 |
|
|
2023
Q3 | $21.5M | Sell |
649,480
-51,337
| -7% | -$1.82M | 0.44% | 36 |
|
|
2023
Q2 | $25.7M | Buy |
700,817
+16,798
| +2% | +$654K | 0.51% | 28 |
|
|
2023
Q1 | $27.9M | Buy |
684,019
+30,836
| +5% | +$1.33M | 0.59% | 20 |
|
|
2022
Q4 | $33.5M | Sell |
653,183
-15,586
| -2% | -$747K | 0.76% | 13 |
|
|
2022
Q3 | $29.3M | Sell |
668,769
-38,012
| -5% | -$1.85M | 0.68% | 15 |
|
|
2022
Q2 | $37.1M | Sell |
706,781
-39,917
| -5% | -$2.03M | 0.8% | 13 |
|
|
2022
Q1 | $38.7M | Buy |
746,698
+16,731
| +2% | +$868K | 0.7% | 17 |
|
|
2021
Q4 | $43.1M | Buy |
729,967
+52,501
| +8% | +$2.6M | 0.75% | 16 |
|
|
2021
Q3 | $29.1M | Buy |
677,466
+2,647
| +0.4% | +$117K | 0.55% | 22 |
|
|
2021
Q2 | $26.4M | Buy |
674,819
+20,242
| +3% | +$787K | 0.47% | 27 |
|
|
2021
Q1 | $23.7M | Sell |
654,577
-9,293
| -1% | -$330K | 0.47% | 28 |
|
|
2020
Q4 | $24.4M | Sell |
663,870
-13,970
| -2% | -$512K | 0.52% | 29 |
|
|
2020
Q3 | $23.6M | Sell |
677,840
-45,071
| -6% | -$1.58M | 0.59% | 26 |
|
|
2020
Q2 | $22.4M | Sell |
722,911
-126,002
| -15% | -$4.28M | 0.58% | 30 |
|
|
2020
Q1 | $26.3M | Buy |
848,913
+37,066
| +5% | +$1.26M | 0.8% | 18 |
|
|
2019
Q4 | $30.2M | Buy |
811,847
+15,664
| +2% | +$558K | 0.75% | 16 |
|
|
2019
Q3 | $27.1M | Sell |
796,183
-6,720
| -0.8% | -$244K | 0.74% | 18 |
|
|
2019
Q2 | $33M | Sell |
802,903
-29,993
| -4% | -$1.19M | 0.9% | 11 |
|
|
2019
Q1 | $33.6M | Buy |
832,896
+23,541
| +3% | +$943K | 0.9% | 13 |
|
|
2018
Q4 | $33.5M | Sell |
809,355
-16,279
| -2% | -$676K | 1.05% | 7 |
|
|
2018
Q3 | $34.5M | Buy |
825,634
+12,889
| +2% | +$496K | 0.88% | 11 |
|
|
2018
Q2 | $28M | Buy |
812,745
+51,863
| +7% | +$1.77M | 0.76% | 16 |
|
|
2018
Q1 | $25.6M | Buy |
760,882
+13,420
| +2% | +$461K | 0.66% | 19 |
|
|
2017
Q4 | $25.7M | Buy |
747,462
+22,961
| +3% | +$783K | 0.66% | 24 |
|
|
2017
Q3 | $24.5M | Sell |
724,501
-33,423
| -4% | -$1.07M | 0.66% | 23 |
|
|
2017
Q2 | $24.2M | Sell |
757,924
-33,168
| -4% | -$1.05M | 0.67% | 21 |
|
|
2017
Q1 | $25.7M | Sell |
791,092
-1,386
| -0.2% | -$43.7K | 0.73% | 18 |
|
|
2016
Q4 | $24.4M | Buy |
792,478
+20,150
| +3% | +$615K | 0.71% | 15 |
|
|
2016
Q3 | $24.8M | Sell |
772,328
-32,208
| -4% | -$1.08M | 0.72% | 14 |
|
|
2016
Q2 | $26.9M | Sell |
804,536
-44,899
| -5% | -$1.43M | 0.8% | 14 |
|
|
2016
Q1 | $23.9M | Buy |
849,435
+12,639
| +2% | +$361K | 0.73% | 16 |
|
|
2015
Q4 | $25.6M | Buy |
836,796
+11,113
| +1% | +$350K | 0.76% | 13 |
|
|
2015
Q3 | $24.6M | Buy |
825,683
+38,573
| +5% | +$1.24M | 0.75% | 13 |
|
|
2015
Q2 | $25M | Sell |
787,110
-6,107
| -0.8% | -$199K | 0.7% | 12 |
|
|
2015
Q1 | $26.2M | Sell |
793,217
-17,715
| -2% | -$563K | 0.71% | 13 |
|
|
2014
Q4 | $24M | Buy |
810,932
+37,653
| +5% | +$1.08M | 0.69% | 15 |
|
|
2014
Q3 | $21.7M | Sell |
773,279
-35,542
| -4% | -$998K | 0.65% | 20 |
|
|
2014
Q2 | $22.8M | Sell |
808,821
-45,416
| -5% | -$1.29M | 0.69% | 19 |
|
|
2014
Q1 | $26M | Buy |
854,237
+55,890
| +7% | +$1.67M | 0.78% | 12 |
|
|
2013
Q4 | $23.2M | Sell |
798,347
-53,838
| -6% | -$1.57M | 0.74% | 13 |
|
|
2013
Q3 | $23.2M | Buy |
852,185
+253
| +0% | +$6.88K | 0.82% | 10 |
|
|
2013
Q2 | $22.6M | Buy |
+851,932
| New | +$23.5M | 0.88% | 8 |
|
Other funds holding PFE
VCM
VPM
Oppenheimer & Co's PFE Position: Q1 2026 in Review
Oppenheimer & Co increased its Pfizer (PFE) stake by 20% in Q1 2026, buying an estimated $3.65M and bringing the position to 831,613 shares worth $23.4M. The position accounts for 0.28% of the portfolio, ranked #59.
Oppenheimer & Co first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $43.1M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Oppenheimer & Co held 831,613 shares of Pfizer worth $23.4M as of Q1 2026.
- Oppenheimer & Co bought 136,995 Pfizer shares in Q1 2026, an estimated $3.65M.
- Pfizer made up 0.28% of Oppenheimer & Co's portfolio in Q1 2026, its #59 holding.
- Oppenheimer & Co first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Oppenheimer & Co's Pfizer position peaked at $43.1M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.